Auswahl der wissenschaftlichen Literatur zum Thema „Lung and breast/ovarian cancer“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Lung and breast/ovarian cancer" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Lung and breast/ovarian cancer"
Prat, Aleix, Barbara Adamo, Cheng Fan, Maria Vidal, Patricia Galvan, Enriqueta Felip, Jose Maria Del Campo, Josep Tabernero und Javier Cortes. „Molecular identification of basal-like breast cancer through genomic analyses across five cancer types.“ Journal of Clinical Oncology 31, Nr. 15_suppl (20.05.2013): 1011. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1011.
Der volle Inhalt der QuelleAchariyapota, Vuthinun, Tuenjai Chuangsuwanich und Mongkol Benjapibal. „Inflammatory Breast Cancer from Metastatic Ovarian Cancer“. Case Reports in Obstetrics and Gynecology 2016 (2016): 1–3. http://dx.doi.org/10.1155/2016/3476143.
Der volle Inhalt der QuelleR., Abhirup H., Priyanka Kenchetty und Aishwarya K. Chidananda. „Breast ovarian cancer syndrome“. International Surgery Journal 8, Nr. 8 (28.07.2021): 2454. http://dx.doi.org/10.18203/2349-2902.isj20213144.
Der volle Inhalt der QuelleAbu-Tineh, Mohammad, Hind Elmalik und Mohamed A. Yassin. „Metastatic Ovarian Cancer Presenting as Inflammatory Breast Cancer: A Case Report“. Case Reports in Oncology 13, Nr. 2 (28.07.2020): 867–74. http://dx.doi.org/10.1159/000508358.
Der volle Inhalt der QuelleBacalbasa, Nicolae, Irina Balescu, Claudia Stoica, Cristina Martac, Valentin Varlas, Andrei Voichitoiu, Lucian Pop, Sorin Petrea, Mihaela Vilcu und Iulian Brezean. „Breast metastases from ovarian cancer“. Romanian Medical Journal 69, S4 (20.06.2022): 14–16. http://dx.doi.org/10.37897/rmj.2022.s4.3.
Der volle Inhalt der QuelleArora, Nimisha, Aline Talhouk, Jessica N. McAlpine, Michael R. Law und Gillian E. Hanley. „Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada“. International Journal of Gynecologic Cancer 29, Nr. 3 (21.12.2018): 593–98. http://dx.doi.org/10.1136/ijgc-2018-000040.
Der volle Inhalt der QuelleHaan, David, Anna Bergamaschi, Yuhong Ning, William Gibb, Michael Kesling, Adriana Pitea, Maryam Nabiyouni et al. „Genome-wide 5hmC profiles to enable cancer detection and tissue of origin classification in breast, colorectal, lung, ovarian, and pancreatic cancers.“ Journal of Clinical Oncology 39, Nr. 15_suppl (20.05.2021): 3044. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.3044.
Der volle Inhalt der QuelleTkaczuk, Katherine R., Paula Rosenblatt, Ranee Mehra, Katherine A. Scilla, Nancy Tait, Katerra Caple, Binbin Yue und Ginette Serrero. „Abstract CT240: On-going phase 1A clinical trial for AG01 an first-in-class anti-progranulin (GP88) monoclonal antibody in patients with advanced malignancies“. Cancer Research 83, Nr. 8_Supplement (14.04.2023): CT240. http://dx.doi.org/10.1158/1538-7445.am2023-ct240.
Der volle Inhalt der QuelleRoland, Adjoby Cassou, Kouamé Arthur Didier, Koffi Achille, Kakou Charles, Konan Joachim, Andriamandimbison Zoly, Ahounkeng Patrick und Nshimirimana Eric. „Metastatic ovarian tumor of a lung cancer at the hospital center of Chauny (France): a case report“. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 6, Nr. 10 (23.09.2017): 4682. http://dx.doi.org/10.18203/2320-1770.ijrcog20174464.
Der volle Inhalt der QuelleYurkovetsky, Zoya, Steven Skates, Aleksey Lomakin, Brian Nolen, Trenton Pulsipher, Francesmary Modugno, Jeffrey Marks et al. „Development of a Multimarker Assay for Early Detection of Ovarian Cancer“. Journal of Clinical Oncology 28, Nr. 13 (01.05.2010): 2159–66. http://dx.doi.org/10.1200/jco.2008.19.2484.
Der volle Inhalt der QuelleDissertationen zum Thema "Lung and breast/ovarian cancer"
Woods, Tonya M. „Extracting meaningful statistics for the characterization and classification of biological, medical, and financial data“. Diss., Georgia Institute of Technology, 2015. http://hdl.handle.net/1853/53857.
Der volle Inhalt der QuelleDucrot, Lucas. „Réseaux bayésiens et analyse de survie pour l’estimation de courbes de pénétrance du cancer broncho-pulmonaire lié à des prédispositions génétiques“. Electronic Thesis or Diss., Sorbonne université, 2024. http://www.theses.fr/2024SORUS055.
Der volle Inhalt der QuelleThis thesis focuses on estimating penetrance curves of genetic diseases from pedigree data, with a particular interest in the genetic predisposition to bronchopulmonary cancer. In this context, it aims to provide clinical and epidemiological results, as well as methodological findings.Genetic counselling is offered to patients with severe family histories of genetic diseases. Geneticists must select from these patients who should be offered genetic testing, and assess the disease risks for these patients and their families. Advances in genetics are rapid, and the number of identified pathogenic variants for different diseases increases each year. This necessitates significant predictive and risk assessment tools, especially in the context of bronchopulmonary cancer. Indeed , the links between the latter and pathogenic variants (such that SFTPA1/SFTPA2 and the genes TP53 and EGFR) are known but still poorly described.Existing methods for assessing the risk of disease occurrence rely on penetrance curves, but their estimation faces challenges due to the small number of patients and the omnipresent selection bias in genetics-collected datasets. To overcome these obstacles, the thesis explores the use of familial data, employing a set of statistical tools including Bayesian networks, mixture models, survival analysis, as well as existing models, for which it attempts to weaken certain assumptions.Chapter 1 provides an overview of the medical context of the thesis, introducing the concepts of genetic diseases and genetic counseling. Chapter 2 serves as a methodological introduction, presenting and illustrating concepts such as survival analysis, Bayesian networks, sum-product algorithm, mixture models and EM algorithm, using examples. It also offers a state-of-the-art review of penetrance curve estimation for genetic diseases and highlights the selection bias in genetics. The chapter concludes with a summary of the addressed research questions.Then, the thesis revolves around four projects. The first two projects, corresponding to chapters 3 and 4, offer predominantly clinical and epidemiological results. The first project, described in Chapter 3, compares different methods for predicting pathogenic variants for breast/ovarian cancers (Manchester Score and family models like BOADICEA). The second project, addressed in Chapter 4, provides estimates of penetrance for interstitial lung disease and bronchopulmonary cancer for carriers of pathogenic variants SFTPA1 and SFTPA2.The last two projects, corresponding to chapters 5 and 6, are more methodological. Chapter 5 is dedicated to developing a new method for estimating the penetrance curve of a genetic disease from pedigree data when the disease presents sporadic cases. It is based on an incidence constraint of the disease in the general population and a parameterization of the relative hazard between carriers and non-carriers of pathogenic variants. Chapter 6 focuses on highlighting the bias introduced by selection in genetics and its consequences on the results of the method developed in Chapter 5. Known correction methods, such as Proband's Phenotype Exclusion Likelihood (PEL) and Genotype-Restricted Likelihood (GRL), combined with our method, are applied to simulated data
Vehmanen, Paula. „Breast cancer-predisposing genes in Finnish breast and ovarian cancer families“. Helsinki : University of Helsinki, 2001. http://ethesis.helsinki.fi/julkaisut/mat/bioti/vk/vehmanen/.
Der volle Inhalt der QuelleFord, Deborah. „Genetic epidemiology of breast and ovarian cancer“. Thesis, Institute of Cancer Research (University Of London), 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.367527.
Der volle Inhalt der QuelleSchofield, Andrew C. „Molecular genetics of breast and ovarian cancer“. Thesis, University of Aberdeen, 1998. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU100481.
Der volle Inhalt der QuelleHuusko, P. (Pia). „Predisposing genes in hereditary breast and ovarian cancer“. Doctoral thesis, University of Oulu, 1999. http://urn.fi/urn:isbn:9514254422.
Der volle Inhalt der QuelleXintaropoulou, Chrysi. „Targeting aerobic glycolysis in breast and ovarian cancer“. Thesis, University of Edinburgh, 2017. http://hdl.handle.net/1842/29525.
Der volle Inhalt der QuelleCheng, Wing-ming Edward. „Emotional well-being in Chinese lung cancer patients“. Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B3197157X.
Der volle Inhalt der QuelleHarbord, Sara Helen Alison. „X chromosome studies and breast and ovarian carcinoma“. Thesis, University of British Columbia, 2007. http://hdl.handle.net/2429/212.
Der volle Inhalt der QuelleBendrik, Christina. „Angiogenesis regulation in hormone dependent breast- and ovarian cancer“. Doctoral thesis, Linköpings universitet, Institutionen för klinisk och experimentell medicin, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-63745.
Der volle Inhalt der QuelleBücher zum Thema "Lung and breast/ovarian cancer"
Cancer sourcebook for women: Basic consumer health information about gynecologic cancers and other cancers of special concern to women, including cancers of the breast, cervix, colon, lung, ovaries, thyroid, and uterus; along with facts about benign conditions of the female reproductive system, cancer risk factors, screening and prevention programs, women's issues in cancer treatment ... 4. Aufl. Detroit, MI: Omnigraphics, 2010.
Den vollen Inhalt der Quelle findenNakamura, Seigo, Daisuke Aoki und Yoshio Miki, Hrsg. Hereditary Breast and Ovarian Cancer. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-4521-1.
Der volle Inhalt der QuellePaula, Dranov, Hrsg. Breast cancer and ovarian cancer: Beating the odds. Reading, Mass: Addison-Wesley, 1992.
Den vollen Inhalt der Quelle findenAoki, Daisuke, Seigo Nakamura und Yoshio Miki, Hrsg. Practical Guide to Hereditary Breast and Ovarian Cancer. Singapore: Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-99-5231-1.
Der volle Inhalt der Quelle1963-, Morrison Patrick J., Hodgson S. V und Haites Neva E. 1947-, Hrsg. Familial breast and ovarian cancer: Genetics, screening, and management. Cambridge, UK: Cambridge University Press, 2002.
Den vollen Inhalt der Quelle finden1963-, Morrison Patrick J., Hodgson S. V und Haites Neva E. 1947-, Hrsg. Familial breast and ovarian cancer: Genetics, screening, and management. Cambridge: Cambridge University Press, 2005.
Den vollen Inhalt der Quelle finden1940-, Hayat M. A., Hrsg. Lung and breast carcinomas. Amsterdam: Elsevier, Academic Press, 2008.
Den vollen Inhalt der Quelle findenLange, Vladimir. Be a survivor: Lung cancer treatment guide. 2. Aufl. Los Angeles, CA: Lange Productions, 2012.
Den vollen Inhalt der Quelle findenHartikainen, Jaana. Genetic predispossition to breast and ovarian cancer in Eastern Finnish population. Kuopio: University of Kuopio, 2007.
Den vollen Inhalt der Quelle findenGenetic testing for breast and ovarian cancer risk: It's your choice. 2. Aufl. Bethesda, Md.]: U.S. Dept. of Health and Human Services, National Institutes of Health, National Cancer Institute, 2005.
Den vollen Inhalt der Quelle findenBuchteile zum Thema "Lung and breast/ovarian cancer"
Workman, Paul. „Reflections and Outlook on Targeting HSP90, HSP70 and HSF1 in Cancer: A Personal Perspective“. In Advances in Experimental Medicine and Biology, 163–79. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-40204-4_11.
Der volle Inhalt der QuelleMasuda, Kenta, Megumi Satake und Daisuke Aoki. „Hereditary Ovarian Cancer“. In Hereditary Breast and Ovarian Cancer, 93–106. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-4521-1_7.
Der volle Inhalt der QuelleClarke, Angus. „Breast and ovarian cancer“. In Harper's Practical Genetic Counselling, 415–20. Eighth edition | Boca Raton : CRC Press, [2020] | Preceded by Practical genetic counselling / Peter S. Harper. 7th ed. 2010.: CRC Press, 2019. http://dx.doi.org/10.1201/9780367371944-31.
Der volle Inhalt der QuelleMiyashita, Minoru, und Takanori Ishida. „Hereditary Breast Cancer“. In Hereditary Breast and Ovarian Cancer, 79–92. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-4521-1_6.
Der volle Inhalt der QuelleKobayashi, Hiroshi. „Chemoprevention for Ovarian Cancer“. In Hereditary Breast and Ovarian Cancer, 149–67. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-4521-1_10.
Der volle Inhalt der QuelleWatanuki, Rurina, Aiko Nagayama, Tetsu Hayashida und Yuko Kitagawa. „Chemoprevention for Breast Cancer“. In Hereditary Breast and Ovarian Cancer, 129–48. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-4521-1_9.
Der volle Inhalt der QuelleBlack, D. M., und E. Solomon. „The BRCA1 gene in sporadic breast and ovarian cancer“. In Ovarian Cancer 3, 39–44. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4757-0136-4_4.
Der volle Inhalt der QuelleLux, Michael P., Mayada R. Bani, Peter A. Fasching und Matthias W. Beckmann. „Hereditary Breast and Ovarian Cancer“. In The Molecular Basis of Human Cancer, 401–21. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-59745-458-2_26.
Der volle Inhalt der QuelleMurakami, Wakana, Mitsuhiro Tozaki, Kelly E. McCann und Stephanie Lee-Felker. „Risk-Based Breast Cancer Screening“. In Hereditary Breast and Ovarian Cancer, 107–28. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-4521-1_8.
Der volle Inhalt der QuelleInuzuka, Mayuko. „Genetic Counseling in Hereditary Breast and Ovarian Cancer“. In Hereditary Breast and Ovarian Cancer, 65–77. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-4521-1_5.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Lung and breast/ovarian cancer"
Lemos, Nathalia Oliveira, Fábio Bagnoli, Maria Antonieta Longo Galvão Silva, José Francisco Rinaldi und Vilmar Marques de Oliveira. „INVASIVE LOBULAR BREAST CANCER METASTATIC TO THE ORBIT: A CASE REPORT“. In XXIV Congresso Brasileiro de Mastologia. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s1048.
Der volle Inhalt der QuelleNguyen, Dat, Larry Rubinstein, Mark E. Sherman, Joseph E. Tomaszewski, Naoko Takebe, Percy Ivy, James H. Doroshow und Sherry X. Yang. „Abstract 3838: Differential expression of Notch1 in lung, ovarian and breast cancers“. In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3838.
Der volle Inhalt der QuelleGEVAERT, O., S. VAN VOOREN und B. DE MOOR. „INTEGRATION OF MICROARRAY AND TEXTUAL DATA IMPROVES THE PROGNOSIS PREDICTION OF BREAST, LUNG AND OVARIAN CANCER PATIENTS“. In Proceedings of the Pacific Symposium. WORLD SCIENTIFIC, 2007. http://dx.doi.org/10.1142/9789812776136_0028.
Der volle Inhalt der QuelleGansmo, Liv B., Merete Bjørnslett, Anne Dørum, Helga Salvesen, Pål Romundstad, Kristian Hveem, Lars Vatten, Per Eystein Lønning und Stian Knappskog. „Abstract 4613: MDM4 SNP 34091 (rs4245739) effect on risk of breast, colon, lung, prostate, endometrial and ovarian cancer“. In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-4613.
Der volle Inhalt der QuelleHalim, Abdel-baset, Lisa M. Dauffenbach, Christopher A. Kerfoot, William R. Stull, Esther Zwick-Wallasch, Richard Scheyer und Giorgio Senaldi. „Abstract 3148: Immunohistochemical analysis of HB-EGF expression in breast, colon, gastric, hepatocellular, lung, ovarian, pancreatic and prostate cancer“. In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3148.
Der volle Inhalt der QuelleFredolini, Claudia, Davide Tamburro, Santosh Goud, Chandler King, Weidong Zhou, Paul Russo, Virginia Espina et al. „Abstract 4787: Novel upfront sample enrichment nanotechnology identifies prostate, breast, colon, ovarian, lung, pancreatic, and melanoma cancer specific biomarker candidates“. In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-4787.
Der volle Inhalt der QuellePirie-Shepherd, Steven R., Iman Jilani, Eric Tucker, David Valenta, Ryon Graf, Amanda Anderson, Dena Marrinucci, Puja Sapra und Eric L. Powell. „Abstract 565: Circulating tumor cell (CTC) detection and 5T4 characterization in breast, ovarian, and lung cancer patients on active therapy“. In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-565.
Der volle Inhalt der QuelleOmofuma, Omonefe O., David P. Turner, Lindsay L. Peterson, Anwar T. Merchant, Jiajia Zhang und Susan E. Steck. „Abstract C033: Dietary advanced glycation end products (dAGEs) and breast cancer by race in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO)“. In Abstracts: Twelfth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; September 20-23, 2019; San Francisco, CA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7755.disp19-c033.
Der volle Inhalt der QuelleBorges, Isabella Sabião, João Victor Aguiar Moreira, Eustaquio Costa Damasceno Junior, Alencar Pereira dos Santos, Gabriela Tomás Alves, Leonardo Peixoto Garcia, Maria Fernanda Prado Rosa et al. „Chronic inflammatory demyelinating polyradiculoneuropathy induced by paclitaxel“. In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.413.
Der volle Inhalt der QuelleLiu, H., und S. Muralitharan. „A Survey of NY-BR-1 Immunohistochemistry in Breast, Ovarian, Endometrial and Lung Cancers: A Correlation Study with Estrogen and Progesterone Receptors.“ In Abstracts: Thirty-Second Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 10‐13, 2009; San Antonio, TX. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-09-6018.
Der volle Inhalt der QuelleBerichte der Organisationen zum Thema "Lung and breast/ovarian cancer"
Tennis, Meredith A., und Peter G. Shields. Gene Environment Interactions in Women with Breast Cancer and Secondary Lung Cancer. Fort Belvoir, VA: Defense Technical Information Center, Juli 2004. http://dx.doi.org/10.21236/ada428946.
Der volle Inhalt der QuelleTennis, Meredith A., und Peter G. Shields. Gene Environment Interactions in Women With Breast and Secondary Lung Cancer. Fort Belvoir, VA: Defense Technical Information Center, Juli 2005. http://dx.doi.org/10.21236/ada456364.
Der volle Inhalt der QuelleBoushey, Carol, Jamy Ard, Lydia Bazzano, Steven Heymsfield, Elizabeth Mayer-Davis, Joan Sabaté, Linda Snetselaar et al. Dietary Patterns and Breast, Colorectal, Lung, and Prostate Cancer: A Systematic Review. U.S. Department of Agriculture, Food and Nutrition Service, Center for Nutrition Policy and Promotion, Nutrition Evidence Systematic Review, Juli 2020. http://dx.doi.org/10.52570/nesr.dgac2020.sr0104.
Der volle Inhalt der QuelleFrost, Marlene H., Charles Loprinzi, Ann Kearns, Jeff Sloan und Debra Barton. Changes in Ovarian Stromal Function in Premenopausal Women Undergoing Chemotherapy for Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, August 2005. http://dx.doi.org/10.21236/ada446278.
Der volle Inhalt der QuelleBarton, Debra, Jeff Sloan, Charles Loprinzi und Ann Kearns. Changes in Ovarian Stromal Function in Premenopausal Women Undergoing Chemotherapy for Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, August 2004. http://dx.doi.org/10.21236/ada428981.
Der volle Inhalt der QuelleGoldgar, David E. Identification and Genetic Mapping of Genes for Hereditary Breast Cancer and Ovarian Cancer in Families Unlinked to BRCA1. Fort Belvoir, VA: Defense Technical Information Center, September 1995. http://dx.doi.org/10.21236/ada301314.
Der volle Inhalt der QuelleNeuhausen, Susan L. Identification and Genetic Mapping of Genes for Hereditary Breast Cancer and Ovarian Cancer in Families Unlinked to BRCA1. Fort Belvoir, VA: Defense Technical Information Center, September 1999. http://dx.doi.org/10.21236/ada382834.
Der volle Inhalt der QuelleFrost, Marlene H. Changes in Ovarian Stromal Function and Associated Symptoms in Premenopausal Women Undergoing Chemotherapy for Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, August 2008. http://dx.doi.org/10.21236/ada510068.
Der volle Inhalt der QuelleWang, Yan, Wenpeng Song, Sicheng Zhou, Jie Tian, Yingxian Dong, Jue Li, Junke Chang et al. Increased risk for subsequent primary lung cancer among female hormone-related cancer patients: a meta-analysis based on over four million cases. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Juli 2022. http://dx.doi.org/10.37766/inplasy2022.7.0044.
Der volle Inhalt der QuelleBattaglia, Tracy, Christine Gunn, Sharon Bak, JoHanna Flacks, Kerrie Nelson, Na Wang, Naomi Ko und Samantha Morton. Reducing Legal Barriers to Help Patients Receive Treatment for Breast and Lung Cancer—The Project SUPPORT Study. Patient-Centered Outcomes Research Institute (PCORI), Juli 2020. http://dx.doi.org/10.25302/07.2020.ad.13046272.
Der volle Inhalt der Quelle